Evidence map›Paper›PMID 39877414›Full record

ArticleIJID regions2025

Characteristics of the 2023-2024

Anna Wolski, Sophie Edouard, Barbara Melo, Philippe Lavrard, Sébastien Cortaredona, Justine Punturo, Aurélia Bordais, Sami Hraiech, Florence Fenollar, Jean-Christophe Lagier and 1 more

Abstract read
In one paragraph

Article in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Impact of point-of-care multiplex PCR for Mycoplasma pneumoniae community-acquired pneumonia in the emergency department.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anna WolskiIHU-Méditerranée Infection, Marseille, France.
Sophie EdouardIHU-Méditerranée Infection, Marseille, France.
Barbara MeloIHU-Méditerranée Infection, Marseille, France.
Philippe LavrardIHU-Méditerranée Infection, Marseille, France.
Sébastien CortaredonaIHU-Méditerranée Infection, Marseille, France.
Justine PunturoService des urgences, Hôpital Nord, AP-HM, Marseille, France.
Aurélia BordaisService des urgences, Hôpital Nord, AP-HM, Marseille, France.
Sami HraiechService de Médecine Intensive - Réanimation, AP-HM, Hôpital Nord, Marseille, France.
Florence FenollarIHU-Méditerranée Infection, Marseille, France.
Jean-Christophe LagierIHU-Méditerranée Infection, Marseille, France.
Nadim CassirIHU-Méditerranée Infection, Marseille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Analysis of current 2023-2024 Methods: A retrospective case series analysis was performed on Results: Clinical and radiological characteristics and outcomes of patients with Conclusions: During the current 2023-2024 epidemic, more hospital admissions for

Indexed as

Co-infectionEpidemicMycoplasma pneumoniaeOutbreakqPCR

Identifiers

PMID39877414
PMCPMC11773249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.